Study finds genes linked to OCD
Sabra Lane: Obsessive compulsive disorder can be debilitating but often goes untreated. Now a new global study has identified the genes linked with the condition. Researchers hope it'll lead to better treatments and diagnosis. Isabel Moussalli reports.
Isabel Moussalli : Dr Leigh Sheppard's earliest memory of her obsessive compulsive disorder was being asked to pick a balloon for her sick brother.
Leigh Sheppard : In my mind, if I chose the wrong balloon, my brother would die. And so I'm making these huge decisions in my mind, but also it's really illogical. Often it doesn't make sense.
Isabel Moussalli : But the now medical doctor didn't receive a diagnosis or treatment until she was 33. Her struggle in finding support led her to start the non-profit OCDWA.
Leigh Sheppard : At my worst, I was almost bedridden. I could barely function and through treatment I now function really well and it's meant that I can return to work.
Isabel Moussalli : And more people could soon receive the diagnosis and treatment they need. That's the hope of a large global group of scientists who've just published significant findings.
Eske Derks : This is the first time, the first large study where we found genes linked to OCD risk.
Isabel Moussalli : Professor Eske Dirks is a senior scientist at Medical Research Institute QIMR Berghofer and was involved in the decade-long project.
Eske Derks : We have access to data from 50,000 patients with OCD and 2 million people who don't have OCD. And then we looked at the genetic profiles and compared them and yeah, we found 250 genes that are increasing OCD risk and 25 of these are very likely to be causal.
Isabel Moussalli : She cautions it doesn't mean they're the only genes as larger studies are being conducted.
Eske Derks : But... It's very important findings I think for several reasons. Because we have a better understanding of the genes that are related to OCD, we can look at existing drugs that might be effective. The other important reason to do this research is that it's also the first step into being able to predict the risk for OCD.
Isabel Moussalli : Dr. Sheppard from OCDWA believes it'll be a landmark moment for her community.
Leigh Sheppard : Identifying the genes and brain regions that are involved in OCD confirms what clinicians and people with lived experience have long understood, which is that OCD is a complex neurobiological condition, not a personality trait or a behavioural choice.
Isabel Moussalli : Sane Australia's CEO, Rachel Green, also hopes it'll break down the stigma.
Rachel Green : OCD is a condition that carries with it some incredible stigma that actually prevents people from seeking help. It's not just wanting to keep your house really clean and it's important not to use it as a term in that sort of context. It can be a really debilitating condition for people who live with it and a very lonely and isolating experience, especially if they haven't yet been able to seek help.
Isabel Moussalli : And she says one place people can seek support is the Sane Australia website.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
34 minutes ago
- ABC News
Private Health insurer Bupa agrees to repay $35 million over incorrectly rejected claims
One of Australia's largest private health insurers has agreed to pay back tens of millions of dollars to thousands of members who had hospital claims incorrectly rejected. Bupa has admitted to engaging in misleading or deceptive conduct and making false or misleading representations by advising members they were not entitled to private health insurance benefits when they were. Bupa reached an agreement with the ACCC on a proposed penalty of $35 million for incorrectly assessing thousands of mixed coverage and uncategorised item claims and related eligibility checks over a five-year period. The company also admitted to engaging in unconscionable conduct relating to its assessment of 388 mixed coverage claims, which included treatment that was covered under a member's private health insurance policy as well as treatment that was not covered under their policy. In a statement, Bupa APAC CEO Nick Stone said the issue should "never have happened" and the company was "deeply sorry for failing to get things right for our customers". Bupa, is Australia's second largest private health insurer and has more than four million members. It has already started compensating affected members, medical providers and hospitals and has so far paid $14.3 million with more than 4,100 affected claims. ACCC Chair Gina Cass-Gottlieb said the consumer watchdog had accepted Bupa's undertaking to continue compensating affected parties. "Bupa's conduct ... caused harm to consumers some of whom delayed, cancelled or went without treatment for which they were, at least partially, covered under their health insurance policies," Ms Cass-Gottlieb said. Bupa said the errors occurred as a result of inaccurate or unclear instructions, training or guidance which meant Bupa didn't always make correct assessments of claims and eligibility checks or act quickly enough to fix issues. Any customers who believe they may have had a historical claim or eligibility check incorrectly assessed can can visit or call Bupa on 134 135. Australian private health insurance industry's peak representative body, Private Healthcare Australia has been contacted for comment.
ABC News
2 hours ago
- ABC News
Teenage boy hospitalised after shark attack at Cabarita Beach
A teenage boy has been airlifted to hospital after he was bitten by a shark at a popular beach on the NSW Far North Coast on Sunday.
News.com.au
3 hours ago
- News.com.au
Do larger breasts increase breast cancer risk? What experts really say
It is a question often asked but rarely answered clearly: does having larger breasts increase your risk of breast cancer? As breast cancer cases in young Aussie women increase at a concerning rate, this question has never been more pressing. According to leading breast cancer surgeon and researcher Dr Sanjay Warrier, the answer is more nuanced than a simple yes or no. 'Breast size in itself is not considered a direct or independent risk factor for breast cancer,' Professor Warrier told 'The assumption that larger breasts may increase risk lacks strong clinical evidence and is not supported by robust data.' However, he urges women with larger breasts to still be proactive about their health, especially if they have other contributing risk factors such as a family history of breast cancer, a sedentary lifestyle, or hormonal influences. Breast density a more important factor More importantly, breast tissue composition, specifically breast density, plays a far more significant role in breast cancer risk than size alone, Prof Warrier said. The BI-RADS (Breast Imaging Reporting and Data System) density scale is used to classify breast tissue, with categories C and D indicating higher density. Women with smaller breasts can still have high breast density, which is why it's important to check the scale. High-density breast tissue is associated with a slightly increased risk of cancer and can make tumours more difficult to detect on standard mammograms, as dense tissue appears white on imaging, which is the same colour as potential tumours. For women with larger breasts, tumours may also be more difficult to detect, sometimes leading to delayed diagnosis. In these cases, contrast-enhanced mammography or a MRI is often recommended for improved clarity. Other factors to consider Prof Warrier also highlighted that women with a higher Body Mass Index (BMI), which may correlate with larger breast size, are at a statistically higher risk of developing breast cancer, especially after menopause. 'Higher body weight means more fat tissue, which in turn increases oestrogen levels, leading to a higher risk of hormone receptor-positive breast cancers,' he said. 'Hormonal exposure across a woman's lifespan, including early menarche, late menopause, and hormone replacement therapy, also elevates risk by increasing the duration of oestrogen exposure.' A preventive approach The key takeaway is that breast size alone does not determine your cancer risk. It's the broader picture of lifestyle, hormonal exposure, weight, family history, and breast density that matters. Prof Warrier advises women of all body types to adopt a preventive approach to breast health, incorporating self-examinations, regular screenings, a wholefood diet, physical activity, and limiting alcohol and processed food intake. Taking a personalised approach to breast cancer screening is also increasingly regarded as best practice. New research proves promising While standard population-based screening generally begins at age 50, emerging evidence suggests that earlier and more frequent screening may benefit those at higher risk. Landmark studies such as the PROCAS trial in the UK and the ROSA Project in Victoria are exploring risk-based models that take these variables into account. These studies are helping to shape new guidelines for tailored screening strategies. This may not only lead to earlier detection but also reduce the need for aggressive treatments and improve overall outcomes by catching cancers at a more manageable stage. Breast cancer diagnoses on the rise It comes as breast cancer diagnoses continue to rise among young women in Australia. Breast cancer is estimated to be the most commonly diagnosed cancer in women aged 20-39, and every day around three women under 40 are diagnosed with breast cancer. Breast cancers in young women tend to have different characteristics and poorer survival outcomes compared with older women, making early detection vital. If you have concerns about your breast cancer risk, make an appointment with your GP to discuss your personal situation and the best screening options for you.
